Reserat 10mg Tablet
By Reserat
Rx
10 Tablet in a Strip

Composition
Serratiopeptidase(10mg)

Manufacturer - Regent Pharmaceuticals
Unit 7 Midas Business Centre, Wantz Road, Dagenham, Essex, United Kingdom, RM10 8PS

Expires on or after
October, 2025

liver
Limited information is available regarding the use of Reserat 10mg Tablet in individuals with liver disease. It is essential to consult your doctor before using this medication to ensure it is safe and appropriate for your condition.

kidney
Limited information is known about the use of Reserat 10mg Tablet in patients with kidney disease. It is advisable to consult your doctor regarding its safe use in such cases.

alcohol
Consult your doctor when consuming alcohol with Reserat 10mg Tablet.

driving
Reserat 10mg Tablet typically does not impact your driving ability.

pregnancy
It is better to consult your doctor before using Reserat 10mg Tablet during pregnancy as specific information regarding its safety is not available.

breastfeeding
It is better to consult your doctor before using Reserat 10mg Tablet.
Habit Forming | No |
Chemical Class | Proteolytic Enzyme |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Proteolytic Enzymes |
₹62.3
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024